DNA repair deficiency as circulating biomarker in prostate cancer.
DNA damage repair
circulating biomarker
circulating tumor DNA
liquid biopsy
prostate cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
12
2022
accepted:
12
01
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
17
2
2023
Statut:
epublish
Résumé
Deleterious aberrations in DNA repair genes are actionable in approximately 25% of metastatic castration-resistant prostate cancers (mCRPC) patients. Homology recombination repair (HRR) is the DNA damage repair (DDR) mechanism most frequently altered in prostate cancer; of note
Identifiants
pubmed: 36793600
doi: 10.3389/fonc.2023.1115241
pmc: PMC9922904
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1115241Informations de copyright
Copyright © 2023 Catalano, Generali, Gatti, Riboli, Paganini, Nesi and Roviello.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
Am J Surg Pathol. 2009 Nov;33(11):1639-45
pubmed: 19701074
Genes Chromosomes Cancer. 2018 Mar;57(3):123-139
pubmed: 29205637
J Clin Med. 2019 Mar 30;8(4):
pubmed: 30934991
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
Oncotarget. 2019 Mar 29;10(25):2421-2422
pubmed: 31069005
Cells. 2020 Sep 02;9(9):
pubmed: 32887373
JAMA Oncol. 2019 Apr 01;5(4):471-478
pubmed: 30589920
Mol Cancer. 2022 Mar 18;21(1):79
pubmed: 35303879
JAMA Oncol. 2021 Jun 04;:
pubmed: 34086042
Clin Cancer Res. 2019 Dec 1;25(23):7035-7045
pubmed: 31383735
BMC Med. 2018 Oct 2;16(1):166
pubmed: 30285732
J Natl Cancer Inst. 2018 Sep 1;110(9):929-934
pubmed: 29931312
Expert Opin Ther Targets. 2022 Nov;26(11):923-936
pubmed: 36519314
N Engl J Med. 2012 Jan 12;366(2):141-9
pubmed: 22236224
JAMA Oncol. 2019 Apr 01;5(4):523-528
pubmed: 30730552
Diagnostics (Basel). 2022 Aug 12;12(8):
pubmed: 36010306
J Natl Cancer Inst. 2016 Jul 10;108(10):
pubmed: 27400876
Nat Genet. 2015 Jul;47(7):736-45
pubmed: 26005866
Cancer Discov. 2021 Apr;11(4):858-873
pubmed: 33811121
Cancer Res. 2012 Nov 1;72(21):5588-99
pubmed: 23118055
Pathol Oncol Res. 2020 Jul;26(3):1417-1427
pubmed: 32377987
Eur Urol. 2019 Mar;75(3):378-382
pubmed: 30337059
Int J Cancer. 2019 Feb 1;144(3):607-614
pubmed: 30265376
Sci Rep. 2017 Dec 12;7(1):17421
pubmed: 29234042
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
J Clin Oncol. 2020 Feb 10;38(5):395-405
pubmed: 31774688
Nat Med. 2021 Nov;27(11):1899-1903
pubmed: 34764486
Clin Cancer Res. 2022 Apr 14;28(8):1518-1530
pubmed: 35091440
J Clin Invest. 2018 Nov 1;128(11):5185
pubmed: 30382943
Cancer Discov. 2018 Apr;8(4):444-457
pubmed: 29367197
BMC Cancer. 2018 Jan 2;18(1):8
pubmed: 29295717
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Cancer Res. 2006 Aug 15;66(16):8109-15
pubmed: 16912188
Cancers (Basel). 2020 Aug 14;12(8):
pubmed: 32823942
J Mol Diagn. 2011 May;13(3):271-81
pubmed: 21497289
JAMA Oncol. 2016 Aug 1;2(8):1014-22
pubmed: 27055085
J Immunother Cancer. 2020 Aug;8(2):
pubmed: 32788235
JCO Precis Oncol. 2017;2017:
pubmed: 29850653
Sci Rep. 2020 Feb 25;10(1):3390
pubmed: 32098980
Curr Drug Metab. 2019;20(4):305-312
pubmed: 30799789
Clin Cancer Res. 2019 Dec 1;25(23):7024-7034
pubmed: 31506389
Cancer Cell. 2020 Oct 12;38(4):489-499.e3
pubmed: 32916128
Ann Oncol. 2020 Sep;31(9):1119-1134
pubmed: 32593798
Br J Cancer. 2011 Oct 11;105(8):1114-22
pubmed: 21989215
J Immunother Cancer. 2018 Apr 17;6(1):29
pubmed: 29665853
J Pers Med. 2021 Mar 28;11(4):
pubmed: 33800556
Prostate. 2015 Mar 1;75(4):390-8
pubmed: 25408531
Clin Cancer Res. 2010 Apr 1;16(7):2115-21
pubmed: 20215531
Front Immunol. 2019 Mar 28;10:603
pubmed: 30984182
Clin Cancer Res. 2021 Mar 15;27(6):1650-1662
pubmed: 33414135
JCO Precis Oncol. 2019;3:
pubmed: 31218271
Lancet Oncol. 2022 Mar;23(3):362-373
pubmed: 35131040
Cancers (Basel). 2019 Dec 29;12(1):
pubmed: 31905736
Front Cell Dev Biol. 2020 Sep 09;8:564601
pubmed: 33015058
Cancer Res. 2001 Feb 15;61(4):1659-65
pubmed: 11245480
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
Cancers (Basel). 2019 Mar 12;11(3):
pubmed: 30871108
Urologia. 2020 Feb;87(1):3-10
pubmed: 31545701
Eur Urol. 2013 Dec;64(6):895-902
pubmed: 23541457
Clin Cancer Res. 2018 Sep 15;24(18):4437-4443
pubmed: 29567812
Int J Mol Sci. 2021 Sep 10;22(18):
pubmed: 34575947
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Front Mol Biosci. 2020 Jun 26;7:122
pubmed: 32671096
Genes (Basel). 2021 Feb 27;12(3):
pubmed: 33673461
J Clin Oncol. 2019 Feb 1;37(4):286-295
pubmed: 30376427
N Engl J Med. 1997 May 15;336(20):1401-8
pubmed: 9145676
Int J Oncol. 2019 Sep;55(3):597-616
pubmed: 31322208
JCO Precis Oncol. 2017;2017:
pubmed: 30211344
Comput Struct Biotechnol J. 2021 Aug 27;19:4931-4940
pubmed: 34527197
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
Trends Cancer. 2020 Nov;6(11):974-984
pubmed: 32517958
Clin Cancer Res. 2017 Nov 15;23(22):6863-6874
pubmed: 28790115
Nat Commun. 2014 Sep 25;5:4988
pubmed: 25255306
J Clin Oncol. 2017 Jan;35(1):40-47
pubmed: 28034081
Cancers (Basel). 2020 Feb 08;12(2):
pubmed: 32046300
J Biol Chem. 2018 Jul 6;293(27):10524-10535
pubmed: 29599286
Int J Mol Sci. 2021 May 24;22(11):
pubmed: 34073818
Cancers (Basel). 2021 May 02;13(9):
pubmed: 34063238
Clin Cancer Res. 2020 Jul 1;26(13):3230-3238
pubmed: 32220891
JCO Precis Oncol. 2017 May 04;1:
pubmed: 34164591
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
Oncotarget. 2016 Dec 13;7(50):82504-82510
pubmed: 27756888
Expert Rev Mol Diagn. 2017 Aug;17(8):781-789
pubmed: 28598696
World J Gastroenterol. 2022 Apr 21;28(15):1503-1507
pubmed: 35582130
Lancet Oncol. 2020 Jan;21(1):162-174
pubmed: 31806540
Cancer Discov. 2017 Sep;7(9):1006-1017
pubmed: 28450425
BMC Cancer. 2018 Feb 13;18(1):179
pubmed: 29433453
Ann Oncol. 2015 Apr;26(4):756-761
pubmed: 25595936
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Clin Chem. 2004 Sep;50(9):1668-70
pubmed: 15331502
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28825054
Expert Opin Ther Targets. 2021 May;25(5):329-333
pubmed: 34225539
Nat Rev Cancer. 2016 Feb;16(2):110-20
pubmed: 26775620
Eur Urol. 2021 Apr;79(4):519-529
pubmed: 33494937
Eur Urol. 2019 Sep;76(3):e69-e72
pubmed: 31176624
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505
pubmed: 31085757
Nat Commun. 2018 Nov 29;9(1):5068
pubmed: 30498206
Prostate. 2018 Apr;78(5):401-407
pubmed: 29368341
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
Sci Rep. 2020 Sep 25;10(1):15745
pubmed: 32978468
J Clin Oncol. 2018 Jun 20;36(18):1847-1852
pubmed: 29652556
Front Oncol. 2019 Apr 26;9:326
pubmed: 31106155
Semin Oncol. 2017 Jun;44(3):187-197
pubmed: 29248130
Int J Mol Sci. 2021 Jul 23;22(15):
pubmed: 34360649
Cold Spring Harb Perspect Med. 2019 Jan 2;9(1):
pubmed: 29530944
N Engl J Med. 2015 Oct 29;373(18):1697-708
pubmed: 26510020
J Natl Cancer Inst. 2017 Dec 01;109(12):
pubmed: 29206995
Cancers (Basel). 2019 Feb 07;11(2):
pubmed: 30736478
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
DNA Repair (Amst). 2016 Feb;38:94-101
pubmed: 26704428
Clin Cancer Res. 2021 Jun 1;27(11):3094-3105
pubmed: 33558422
Eur Urol. 2019 Apr;75(4):667-675
pubmed: 30638634
Hum Mutat. 2018 Mar;39(3):394-405
pubmed: 29215764
Cancers (Basel). 2020 Aug 10;12(8):
pubmed: 32785174
Int J Cancer. 2019 Sep 1;145(5):1209-1220
pubmed: 30666631
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Eur Urol. 2019 May;75(5):743-749
pubmed: 30309687
Cancers (Basel). 2021 Nov 14;13(22):
pubmed: 34830851
Cancers (Basel). 2022 Jul 04;14(13):
pubmed: 35805043
Nature. 2003 Jan 23;421(6921):436-40
pubmed: 12540918